Circumvent the Tariff challenges with an agile supply chain Consulting
Supply Chain Ecosystem Analysis now part of DBMR Reports
Global Veterinary Ivf Market
Market Size in USD Billion
CAGR :
%
USD
1.80 Billion
USD
2.76 Billion
2024
2032
Forecast Period
2025 –2032
Market Size(Base Year)
USD
1.80 Billion
Market Size (Forecast Year)
USD
2.76 Billion
CAGR
5.50
%
Major Markets Players
Hamilton ThorneInc.
Esco Medical
Zoetis Services LLC
Imy Technologies
Minitube AGetech Inc
Global Veterinary In Vitro Fertilization (IVF) Market Segmentation, By Products & Services (Equipment, Reagents & Kits, and Services), Animal Type (Livestock Animal, and Companion Animals), Technique (Artificial Insemination, Embryo Transfer, Ovum Pickup, and In vitro Maturation), Distribution Channel (Hospitals, Dialysis Centers, Home Care Settings, and Others), Distribution Channel (Direct Tenders, Retail Sales, Online Sales, and Others), End User (Veterinary Fertility Clinics, Veterinary Hospitals, Surgical Centers, Research Laboratories, Cryobanks, and Others) – Industry Trends and Forecast to 2032
Global Veterinary in Vitro Fertilization (IVF) Market Analysis
The global veterinary in vitro fertilization (IVF) market is experiencing significant growth, driven by the rising demand for advanced reproductive technologies in animal breeding, particularly in livestock and companion animals. Increasing awareness about genetic advancements and the growing importance of improving animal health, fertility rates, and offspring quality are key factors boosting the market. Technological advancements in IVF techniques, such as embryo transfer, sperm preservation, and cryopreservation, are further contributing to the expansion of the market. The rising adoption of assisted reproductive technologies in the livestock industry to enhance productivity and ensure food security is creating new opportunities for market growth. The veterinary IVF market is also benefiting from favorable regulatory frameworks and government initiatives aimed at improving animal breeding practices and overall herd health.
Global Veterinary in Vitro Fertilization (IVF) Market Size
Global veterinary in vitro fertilization (IVF) market size was valued at USD 1.80 billion in 2024 and is projected to reach USD 2.76 billion by 2032, with a CAGR of 5.50% during the forecast period of 2025 to 2032. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Global Veterinary in vitro fertilization (IVF) Market Trends
“Rise in Focus on advanced reproductive technologies”
One key trend in the Global Veterinary In Vitro Fertilization (IVF) Market is the increasing adoption of advanced reproductive technologies in livestock breeding to improve productivity and genetic diversity. As global demand for high-quality meat and dairy products continues to rise, particularly in developing regions, farmers and breeders are increasingly turning to IVF and other assisted reproductive technologies to enhance herd quality, optimize reproductive efficiency, and increase yields. These technologies allow for better control over breeding processes, reducing the risks associated with traditional methods, and promoting the preservation of desirable genetic traits. This trend is especially prominent in regions such as North America and Europe, where advanced veterinary practices are more widely implemented, but is also gaining momentum in emerging markets.
In addition, innovations in IVF techniques, such as improved cryopreservation methods and more effective embryo transfer procedures, are making the process more accessible and successful. These advancements are reducing the overall cost and improving the success rates of veterinary IVF, encouraging wider adoption among breeders, especially in the livestock and equine industries. The use of cutting-edge technologies, such as genomic selection and embryo sexing, is also gaining traction, allowing breeders to select for specific traits and enhance genetic outcomes. This growing integration of technological innovations in the veterinary IVF market is expected to drive future growth and reshape breeding practices on a global scale.
Report Scope and Global Veterinary in vitro fertilization (IVF) Market Segmentation
Attributes
Global Veterinary in vitro fertilization (IVF) Key Market Insights
Segments Covered
By Products & Services: Equipment, Reagents & Kits, and Services
By Animal Type: Livestock Animal, And Companion Animals
By Technique: Artificial Insemination, Embryo Transfer, Ovum Pickup, and In Vitro Maturation
By Distribution Channel: Direct Tenders, Retail Sales, Online Sales and Others
By End User: Veterinary Fertility Clinics, Veterinary Hospitals, Surgical Centers, Research Laboratories, Cryobanks, and Others
Countries Covered
U.S., Canada, and Mexico, Germany, U.K., France, Italy, Spain, Russia, Switzerland, Turkey, Belgium, Netherlands and Rest of Europe, China, India, Japan, South Korea, Indonesia, Thailand, Malaysia, Philippines, Singapore, Australia & New Zealand and Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel and Rest of Middle East and Africa
Key Market Players
Hamilton Thorne, Inc. (US.), Esco Medical (Singapore), Zoetis Services Llc (U.S.), Imv Technologies (France), Minitube (Germany), Agetech Inc (U.S.), Orgensen Laboratories (U.S.), Bovine Elite Llc (U.S.), Kruuse, Equine Fertility Centre (Denmark), Veterinary Group (UAE), Stateline Veterinary Service (U.S.), Trans Ova Genetics (U.S.), and Tri-Mitsu Pharmaceuticals (India) among others
Market Opportunities
Increase in research and developmental efforts
Advancements in reproductive technology
Increase in pet ownerships
Value Added Data Infosets
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Global Veterinary in Vitro Fertilization (IVF) Market Definition
Veterinary in vitro fertilization (IVF) is a reproductive technology used in animal husbandry and veterinary medicine that involves the collection of oocytes (eggs) from female animals, which are then fertilized with sperm in a controlled laboratory environment, outside the animal's body. This technique allows for the creation of embryos that can be subsequently transferred to recipient females, facilitating selective breeding, genetic improvement, and the preservation of endangered species.
Global Veterinary in Vitro Fertilization (IVF) Market Dynamics
Drivers
Rising Prevalence of Chronic Disease
The growing demand for high-yield livestock, such as cattle (bovine) and sheep (ovine), significantly propels the global veterinary In Vitro Fertilization (IVF) market. As the world’s population expands, the necessity for sustainable food sources, particularly in livestock, becomes more pronounced. Traditional breeding methods often hinder genetic improvement and production efficiency. In contrast, IVF technology enhances breeding programs, allowing for considerable advancements in livestock genetics and productivity. The adoption of advanced reproductive technologies, such as IVF, is especially beneficial in regions facing challenges related to livestock productivity, such as climate change and resource limitations. By optimizing breeding programs and boosting livestock production, IVF technology plays a crucial role in enhancing food security and promoting sustainable agricultural development.
For instance, in August 2023, according to an article published by Taylor & Francis Group, globally, there are approximately 19.6 billion chickens, 1.4 billion cattle, and 980 million pigs raised as livestock (2014). In Africa alone, livestock populations in 2018 included 2 billion poultry, 438 million goats, 384 million sheep, 356 million cattle, 40.5 million pigs, nearly 31 million camels, and 38 million equines (2020)
Rising Demand for Companion Animals
The increasing rates of pet adoption and the growing demand for genetic screening in companion animals, including horses, dogs, and cats, are significant drivers of the global veterinary In Vitro Fertilization (IVF) market. As more people embrace pet ownership and view pets as integral family members, the focus on their health and well-being has intensified. This shift in attitude has led to a rising interest in advanced reproductive technologies such as IVF, which enhance breeding practices and support the health of companion animals. Pet owners are increasingly seeking genetic screening to ensure the health of their animals, identify hereditary conditions, and improve breeding outcomes. IVF plays a critical role in this process by facilitating the breeding of genetically superior animals while minimizing health risks associated with inbreeding. The ability to select for desirable traits and conduct genetic assessments empowers breeders to produce healthier, high-quality companion animals that meet the evolving demands of pet owners.
For instance, in September 2024, according to an article published by GlobalPETS, in South Korea, pets are increasingly regarded as family members, especially with the growing number of single-person households. In 2022, the average annual expenditure on pet services and products reached USD255 per person, the highest in four years, up from USD196 in 2019 and USD233 in 2021. Similar spending trends are observed in other East Asian countries such as China and Japan. This growing financial commitment to pet care underscores the rising demand for companion animals, which is expected to drive the global veterinary In Vitro Fertilization (IVF) market
Opportunities
Increase In Research and Developmental Efforts
The increase in research and developmental efforts within the global veterinary In Vitro Fertilization (IVF) market represents a significant opportunity for various stakeholders, including veterinary clinics, biotechnology companies, and academic institutions. Enhanced R&D can lead to the development of innovative techniques, optimized protocols, and improved success rates for IVF in both companion animals and livestock. This not only meets the growing demand for advanced reproductive technologies but also positions veterinary IVF as a crucial component of animal breeding and health management practices. One of the key benefits of increased R&D efforts is the improvement of existing IVF techniques. Ongoing research can lead to the refinement of culture media, embryo selection processes, and cryopreservation methods. For instance, the development of more effective culture media can enhance embryo development and viability, thus improving overall success rates. As veterinary practitioners become more equipped with advanced techniques, they can offer better services to clients, boosting the market’s reputation and driving demand for such specialized services.
For instance, in July 2022, according to article published in The Science World, In Vitro Fertilization (IVF) technology has made significant advancements in the field of veterinary practice, offering new possibilities for animal breeding and reproductive management
Advancements In Reproductive Technology
The advancement in reproductive technology, particularly in vitro fertilization (IVF) for animals, represents a significant growth prospect for the veterinary and livestock markets. As the agricultural industry, breeders, and even pet owners seek innovative ways to improve genetic lines, the use of sophisticated reproductive technologies, such as IVF, is gaining momentum. IVF allows for controlled breeding programs that can enhance desirable traits in livestock, such as disease resistance, productivity, and physical attributes, leading to more efficient and profitable farming practices. For pet owners, particularly those invested in purebred or rare animal breeds, IVF offers a controlled approach to ensuring the genetic quality and health of future generations, minimizing hereditary issues while fostering favorable characteristics. Additionally, the demand for preserving and enhancing endangered species through advanced reproductive technologies has opened up a specialized niche market. Innovations such as embryo freezing, gamete preservation, and genetic screening add another layer of value, as they allow for long-term storage and selection of superior genetics for future breeding purposes.
In April 2021, According to the article published by Hamilton Thorne, The Vibe anti-vibration platform, combined with Hamilton Thorne's precision instruments, represents a significant technological advancement in In Vitro Fertilization (IVF) for animals. In IVF procedures, even the slightest vibrations can negatively affect embryo quality and development, making a vibration-free environment essential for optimal outcomes. The Vibe platform is designed to minimize these disruptions by providing a stable, vibration-free surface for sensitive IVF equipment
Restraints/Challenges
Risk Of Disease Transmission During IVF Procedures
The success of veterinary IVF depends heavily on maintaining strict hygiene and sterilization protocols throughout the process. However, if proper precautions are not followed, there is a significant risk of contamination that can lead to disease outbreaks. During IVF procedures, several biological materials, such as sperm, oocytes, and embryos, are handled, often requiring multiple stages of transfer between lab environments and animals. Shared use of equipment such as catheters, incubators, and transfer tools can further heighten the risk of microbial contamination if not adequately sterilized between uses.
The risk of disease transmission acts as a barrier to the adoption of IVF technologies in veterinary settings. Veterinary clinics, breeders, and livestock producers may hesitate to invest in IVF solutions without confidence in robust safety measures. Frequent disease outbreaks could erode trust in IVF services and impose additional costs on veterinary professionals and breeders in the form of quarantine, medical treatments, or culling of infected animals.
For instance, in September 2022, according to an article published by International Veterinary Information Service, Feline Immunodeficiency Virus (FIV) is present in the semen of both chronically and newly infected cats, with the virus detectable even before the infected cat develops antibodies. Transmission of FIV from male to female has been documented through artificial insemination using fresh semen via laparoscopy
Lack Of Awareness in Underdeveloped Markets
In many underdeveloped markets, the adoption of veterinary In Vitro Fertilization (IVF) technologies faces significant challenges due to a lack of awareness. This limitation is primarily rooted in inadequate infrastructure and insufficient education about the benefits of IVF in animal breeding and health management. Farmers and breeders in these regions may not be familiar with the advantages that IVF can offer, such as enhanced genetic diversity, improved reproductive outcomes, and the potential for disease management.
Moreover, the scarcity of veterinary professionals trained in advanced reproductive technologies contributes to this knowledge gap. Without access to education and resources, livestock producers may remain reliant on traditional breeding methods, which could hinder the growth of the IVF market. This lack of awareness not only restricts the potential benefits of IVF technologies but also perpetuates low investment levels in veterinary services.
For instance, in 2022, according to an article published by AiGGPA, infertility is a significant issue among cattle and buffalo in Madhya Pradesh, driven by livestock owners' ignorance and a lack of awareness, as well as inadequate treatment facilities in remote areas. These factors further hinder breed improvement programs, complicating efforts to address infertility in these animals. This situation underscores the "lack of awareness in underdeveloped markets" and highlights how insufficient knowledge and limited access to veterinary resources are substantial challenges for the global veterinary In Vitro Fertilization (IVF) market
This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Veterinary in Vitro Fertilization (IVF) Market Scope
The market is segmented on the basis of products & services, animal type, technique, distribution channel, and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Global Veterinary in vitro fertilization (IVF) Market Regional Analysis
The market is analyzed and market size insights and trends are provided by country, products & services, animal type, technique, distribution channel, and end user as referenced above.
The countries covered in the market are U.S., Canada, and Mexico, Germany, France, U.K., Italy, Spain, Russia, Turkey, Poland, Belgium, Austria, Netherlands, Switzerland, Hungary, Ireland, Lithuania, Norway, and Rest of Europe, China, Japan, India, Australia, South Korea, Thailand, Indonesia, Malaysia, Vietnam, Philippines, Singapore, and Rest of Asia-Pacific, Brazil, Argentina, Peru and Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Kuwait, Israel, and rest of Middle East and Africa.
North America is expected to dominate the market due to the region's well-established livestock industry, high adoption of advanced reproductive technologies, availability of skilled veterinary professionals, and strong support from government and private initiatives aimed at improving animal productivity and genetic quality.
Asia-Pacific is expected to be the fastest growing due to its expanding healthcare infrastructure, rising demand for companion animals, and increase in veterinary clinics offering IVF services.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Global Veterinary in vitro fertilization (IVF) Market Share
The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.
Global Veterinary in vitro fertilization (IVF) Market Leaders Operating in the Market Are:
Hamilton Thorne, Inc. (U.S.)
Esco Medical (Singapore)
Zoetis Services LLC (U.S.)
Imy Technologies (U.S.)
Minitube (Germany)
Agetech Inc (U.S.)
Orgensen Laboratories (U.S.)
Bovine Elite LLC (U.S.)
Kruuse (Denmark)
Equine Fertility Centre (UK)
Veterinary Group (U.S.)
Stateline Veterinary Service (U.S.)
Trans Ova Genetics (U.S.)
Tri-Mitsu Pharmaceuticals (Japan)
Latest Developments in Global Veterinary in vitro fertilization (IVF) Market
In September 2024, Zoetis and Danone announced a strategic partnership to enhance sustainability in dairy farming through genetics. By combining their expertise, they aimed to improve animal health, reduce environmental impact, and create resilient dairy herds, aligning with growing consumer demand for sustainable dairy products
In October 2024, Esco Medical launched the MIRI Laminar Flow (MLF) Cabinet, designed for IVF clinics and laboratories. This innovative cabinet utilized vertical airflow and advanced filtration to ensure optimal sample protection, safety, and efficiency in laboratory environments
In September 2024, IMV Technologies Group acquired UD-Vet B.V. UD-Vet are a leading provider of Veterinary practice equipment and other veterinary imaging modalities, based in Utrecht, Netherlands and Brussels, Belgium with a reach throughout the Benelux region
In October 2023, Hamilton Thorne Ltd. has acquired Gynetics Medical Products N.V., enhancing its consumables portfolio in the European IVF market. This strategic acquisition increases recurring revenue opportunities and expands product offerings, reinforcing Hamilton Thorne’s commitment to high-quality assisted reproductive technologies
In September 2022, Zoetis announced the completion of its acquisition of Jurox, enhancing its product range and global presence. This acquisition strengthened Zoetis' anesthetic portfolio with Alfaxan and provided valuable insights into the Australian animal health market
SKU-24594
Get online access to the report on the World's First Market Intelligence Cloud
Interactive Data Analysis Dashboard
Company Analysis Dashboard for high growth potential opportunities
Research Analyst Access for customization & queries
Competitor Analysis with Interactive dashboard
Latest News, Updates & Trend analysis
Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
Claudio Rondena
Group Business Development & Strategic Marketing Director, C.O.C Farmaceutici SRL
"This morning we were involved in the first part, the data presentation of MKT analysis, selected abstract from your work. The board team was really impressed and very appreciated, as well."
David Manning - Thermo Fisher Scientific
Director, Global Strategic Accounts,
Dear Ricky, I want to thank you for the excellent market analysis (LIMS INSTALLED BASE DATA) that you and your team delivered, especially end of year on short notice.
Sachin and Shraddha captured the requirements, determined their path forward and executed quickly.
You, Sachin and Shraddha have been a pleasure to work with – very responsive, professional and thorough.
Your work is much appreciated.
Manager - Market Analytics,
Uriah D. Avila - Zeus Polymer Solutions
Thank you for all the assistance and the level of detail in the market report. We are very pleased with the results and the customization. We would like to continue to do business.
Business Development Manager,
(Pharmaceuticals Partner for Nasal Sprays) | Renaissance Lakewood LLC
DBMR was attentive and engaged while discussing the Global Nasal Spray Market. They understood what we were looking for and was able to provide some examples from the report as requested. DBMR Service team has been responsive as needed. Depending on what my colleagues were looking for, I will recommend your services and would be happy to stay connected in case we can utilize your research in the future.
Business Intelligence and Analytics,
Ipsen Biopharm Limited
We are impressed by the CENTRAL PRECOCIOUS PUBERTY (CPP) TREATMENT report - so a BIG thanks to you colleagues.
Competition Analyst,
Basler Web
I just wanted to share a quick note and let you know that you guys did a really good job. I’m glad I decided to work with you. I shall continue being associated with your company as long as we have market intelligence needs.
Marketing Director,
Buhler Group
It was indeed a good experience, would definitely recommend and come back for future prospects.
COO,
A global leader providing Drug Delivery Services
DBMR did an outstanding job on the Global Drug Delivery project, We were extremely impressed by the simple but comprehensive presentation of the study and the quality of work done. This report really helped us to access untapped opportunities across the globe.
Marketing Director,
Philips Healthcare
The study was customized to our targets and needs with well-defined milestones. We were impressed by the in-depth customization and inclusion of not only major but also minor players across the globe. The DBMR Market position grid helped us to analyze the market in different dimension which was very helpful for the team to get into the minute details.
Product manager,
Fujifilms
Thankful to the team for the amazing coordination, and helping me at the last moment with my presentation. It was indeed a comprehensive report that gave us revenue impacting solution enabling us to plan the right move.
Investor relations,
GE Healthcare
Thank you for the report, and addressing our needs in such short time. DBMR has outdone themselves in this project with such short timeframe.
Market Analyst,
Medincell
We found the results of this study compelling and will help our organization validate a market we are considering to enter. Thank you for a job well done.
Andrew - Senior Global Marketing Manager,
Medtronic (US)
I want to thank you for your help with this report – It’s been very helpful in our business planning and it well organized.
Amarildo - Manager, Global Strategic Alignment
MasterCard
We believe the work done by Data Bridge Team for our requirements in the North America Loyalty Management Market was fantastic and would love to continue working with your team moving forward.
Tor Hammer
Green Nexus LLc
Thank you for your quick response to this unfortunate circumstance. Please extend my thanks to your reach team. I will be contacting you in the future with further projects
I acknowledge the difficulty given by the very short warning for this report, and I think that its quality and your delivering time have been very satisfying.
Obviously, as a provider Data Bridge Market Research will be considered as a plus for future needs of Nippon Gases.
Yuki Kopyl (Asian Business Development Department)
UENO FOOD TECHNO INDUSTRY, LTD. (JAPAN)
Xylose report was very useful for our team. Thank you very much & hope to work with you again in the future